These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3031130)

  • 21. Relapsing encephalomyelitis following transfer of partial immunity to JHM virus.
    Shubin RA; Sussman MA; Fleming JO; Stohlman SA
    Microb Pathog; 1990 May; 8(5):305-14. PubMed ID: 1977071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronavirus JHM induced demyelinating disease: specific domains on the E2-protein are associated with neurovirulence.
    Wege H; Winter J; Massa P; Dörries R; ter Meulen V
    Adv Exp Med Biol; 1987; 218():307-20. PubMed ID: 2449042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo and in vitro models of demyelinating disease. IX. Progression of JHM virus infection in the central nervous system of the rat during overt and asymptomatic phases.
    Sorensen O; Coulter-Mackie MB; Puchalski S; Dales S
    Virology; 1984 Sep; 137(2):347-57. PubMed ID: 6091333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Background paper. On the role of the immune response in the course of coronavirus JHM-induced encephalomyelitides in mice and rats.
    Dörries R
    Adv Exp Med Biol; 1990; 276():623-7. PubMed ID: 1966458
    [No Abstract]   [Full Text] [Related]  

  • 25. Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluid.
    Reiber H; Teut M; Pohl D; Rostasy KM; Hanefeld F
    Mult Scler; 2009 Dec; 15(12):1466-80. PubMed ID: 19995844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune mediated clearance of JHM virus from the central nervous system.
    Sussman MA; Fleming JO; Allen H; Stohlman SA
    Adv Exp Med Biol; 1987; 218():399-410. PubMed ID: 2829552
    [No Abstract]   [Full Text] [Related]  

  • 27. Quantitation, phenotypic characterization and in situ localization of lymphoid cells in the brain parenchyma of rats with differing susceptibility to coronavirus JHM-induced encephalomyelitis.
    Dörries R; Schwender S; Imrich H; Harms H; ter Meulen V
    Adv Exp Med Biol; 1990; 276():629-35. PubMed ID: 1966459
    [No Abstract]   [Full Text] [Related]  

  • 28. Characterization of murine hepatitis virus (JHM) RNA from rats with experimental encephalomyelitis.
    Jackson DP; Percy DH; Morris VL
    Virology; 1984 Sep; 137(2):297-304. PubMed ID: 6091331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid immunoglobulins and virus-specific antibodies in disorders affecting the facial nerve.
    Weber T; Jürgens S; Lüer W
    J Neurol; 1987 Jun; 234(5):308-14. PubMed ID: 3612202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-endorphin protects mice from neurological disease induced by the murine coronavirus MHV-JHM.
    Gilmore W; Moradzadeh DS
    J Neuroimmunol; 1993 Oct; 48(1):81-90. PubMed ID: 8227310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the role of different lymphocyte subpopulations in the course of coronavirus MHV IV (JHM)-induced encephalitis in Lewis rats.
    Schwender S; Hein A; Imrich H; Dörries R
    Adv Exp Med Biol; 1993; 342():425-30. PubMed ID: 8209763
    [No Abstract]   [Full Text] [Related]  

  • 32. Virological aspects of measles virus-induced encephalomyelitis in Lewis and BN rats.
    Liebert UG; ter Meulen V
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1715-22. PubMed ID: 3495633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody prevents virus reactivation within the central nervous system.
    Lin MT; Hinton DR; Marten NW; Bergmann CC; Stohlman SA
    J Immunol; 1999 Jun; 162(12):7358-68. PubMed ID: 10358187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo and in vitro models of demyelinating diseases--VIII: Genetic, immunologic and cellular influences on JHM virus infection of rats.
    Sorensen O; Beushausen S; Puchalski S; Cheley S; Anderson R; Coulter-Mackie M; Dales S
    Adv Exp Med Biol; 1984; 173():279-98. PubMed ID: 6331119
    [No Abstract]   [Full Text] [Related]  

  • 35. Recruitment kinetics and composition of antibody-secreting cells within the central nervous system following viral encephalomyelitis.
    Tschen SI; Bergmann CC; Ramakrishna C; Morales S; Atkinson R; Stohlman SA
    J Immunol; 2002 Mar; 168(6):2922-9. PubMed ID: 11884463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronavirus JHM-induced demyelinating encephalomyelitis in rats: influence of immunity on the course of disease.
    Wege H; Watanabe R; Koga M; Ter Meulen V
    Prog Brain Res; 1983; 59():221-31. PubMed ID: 6320266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequence of murine coronavirus JHM induced neuropathological changes in rats.
    Koga M; Wege H; ter Meulen V
    Neuropathol Appl Neurobiol; 1984; 10(3):173-84. PubMed ID: 6330603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronavirus induced primary demyelination: indications for the involvement of a humoral immune response.
    Zimprich F; Winter J; Wege H; Lassmann H
    Neuropathol Appl Neurobiol; 1991 Dec; 17(6):469-84. PubMed ID: 1666174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population dynamics of lymphocyte subsets in the central nervous system of rats with different susceptibility to coronavirus-induced demyelinating encephalitis.
    Dörries R; Schwender S; Imrich H; Harms H
    Immunology; 1991 Nov; 74(3):539-45. PubMed ID: 1663079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early and late CNS-effects of corona virus infection in rats.
    Nagashima K; Wege H; ter Meulen V
    Adv Exp Med Biol; 1978; 100():395-409. PubMed ID: 211826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.